Cardiovascular presentations during the COVID-19 pandemic: an interrupted time series analysis.

Hari Prakash Sritharan, Harrison Nguyen, Usaid Khalil Allahwala, Ravinay Bhindi
{"title":"Cardiovascular presentations during the COVID-19 pandemic: an interrupted time series analysis.","authors":"Hari Prakash Sritharan, Harrison Nguyen, Usaid Khalil Allahwala, Ravinay Bhindi","doi":"10.1093/pubmed/fdae248","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The broader implications of the Coronavirus disease 2019 pandemic on cardiovascular hospitalizations remain unclear. We aimed to assess trends in cardiovascular presentations during the Coronavirus disease 2019 pandemic.</p><p><strong>Methods: </strong>This multicentre study examined cardiovascular presentations from March 2018 to February 2023. Patients with cardiovascular presentations were identified through administrative health records using ICD-10-AM diagnosis codes. Four key study periods were analysed: T0-pre-pandemic, T1-first lockdown, T2-easing of restrictions and T3-release of restrictions and widespread vaccination. Interrupted time series analysis was used to predict weekly cardiovascular presentations, with the mean difference between actual and predicted numbers assessed for significance.</p><p><strong>Results: </strong>Overall, 116 518 patients were included across three major public hospitals in Australia. Cardiovascular presentations were significantly lower in T1 than predicted, with a mean decline of 13.1% (SD 16.2%; P = 0.004). There was a significant difference between the expected and actual number of most cardiovascular presentations in T2 and T3, apart from a significant reduction in cardiomyopathy and heart failure presentations during T3 (4.5% [SD 23.7%]; P = 0.007).</p><p><strong>Conclusions: </strong>Cardiovascular presentations were significantly lower during the initial lockdown phase of the COVID-19 pandemic; this attenuated with easing of social restrictions and widespread vaccination, except for persistent reduction in cardiomyopathy and heart failure presentations.</p>","PeriodicalId":94107,"journal":{"name":"Journal of public health (Oxford, England)","volume":" ","pages":"3-8"},"PeriodicalIF":3.1000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11879051/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of public health (Oxford, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/pubmed/fdae248","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The broader implications of the Coronavirus disease 2019 pandemic on cardiovascular hospitalizations remain unclear. We aimed to assess trends in cardiovascular presentations during the Coronavirus disease 2019 pandemic.

Methods: This multicentre study examined cardiovascular presentations from March 2018 to February 2023. Patients with cardiovascular presentations were identified through administrative health records using ICD-10-AM diagnosis codes. Four key study periods were analysed: T0-pre-pandemic, T1-first lockdown, T2-easing of restrictions and T3-release of restrictions and widespread vaccination. Interrupted time series analysis was used to predict weekly cardiovascular presentations, with the mean difference between actual and predicted numbers assessed for significance.

Results: Overall, 116 518 patients were included across three major public hospitals in Australia. Cardiovascular presentations were significantly lower in T1 than predicted, with a mean decline of 13.1% (SD 16.2%; P = 0.004). There was a significant difference between the expected and actual number of most cardiovascular presentations in T2 and T3, apart from a significant reduction in cardiomyopathy and heart failure presentations during T3 (4.5% [SD 23.7%]; P = 0.007).

Conclusions: Cardiovascular presentations were significantly lower during the initial lockdown phase of the COVID-19 pandemic; this attenuated with easing of social restrictions and widespread vaccination, except for persistent reduction in cardiomyopathy and heart failure presentations.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19 大流行期间的心血管症状:间断时间序列分析。
背景:2019年冠状病毒病大流行对心血管住院治疗的广泛影响仍不清楚。我们旨在评估冠状病毒病 2019 年大流行期间心血管疾病的发病趋势:这项多中心研究调查了 2018 年 3 月至 2023 年 2 月期间的心血管病例。通过使用 ICD-10-AM 诊断代码的行政健康记录确定心血管疾病患者。对四个关键研究时段进行了分析:T0-大流行前、T1-首次封锁、T2-放松限制、T3-放开限制并广泛接种疫苗。采用间断时间序列分析预测每周心血管病发病情况,并评估实际发病人数与预测人数之间的平均差异是否显著:澳大利亚三家大型公立医院共纳入了 116 518 名患者。T1的心血管病发病率明显低于预测值,平均下降了13.1%(标准差为16.2%;P = 0.004)。除了心肌病和心力衰竭的发病率在 T3 期显著下降(4.5% [SD 23.7%];P = 0.007)外,大多数心血管疾病的发病率在 T2 期和 T3 期的预期和实际发病率之间存在显著差异:结论:在COVID-19大流行的最初封锁阶段,心血管病发病率明显降低;随着社会限制的放松和疫苗接种的普及,心血管病发病率有所下降,但心肌病和心力衰竭发病率持续下降。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Gas stove and respiratory health: a cross-sectional study and a cohort study in Denmark, 2000-2018. Equity considerations when making decisions to scale-up health interventions: a review and analysis of scalability assessment resources. Predictive value of the EHIS-PAQ for all-cause mortality. Positive effects of student-led health promotion activities at mass gathering events on health modification behaviors. 'Dampening the flames turmoil' international perspectives on sources of moral harms and their implications for health policy and practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1